Effect of iNOS inhibitor S-methylisothiourea in monosodium iodoacetate-induced osteoathritic pain: Implication for osteoarthritis therapy

Amar S. More, Rashmi R. Kumari, Gaurav Gupta, Madhu C. Lingaraju, Venkanna Balaganur, Nitya N. Pathak, Dhirendra Kumar, Dinesh Kumar, Anil K. Sharma, Surendra K. Tandan

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Much information is available on the role of nitric oxide (NO) in osteoarthritis (OA). However, its role has not been studied in the monosodium iodoacetate (MIA)-induced model of osteoarthritic pain. The present study was undertaken in rats to investigate the effect of iNOS inhibitor S-methylisothiourea (SMT) in MIA-induced osteoathritic pain and disease progression in rats. Osteoarthritis was produced by single intra-articular injection of the MIA in the right knee joint on day 0. Treatment groups were orally gavazed with different doses of SMT (10, 30 and 100 mg/kg) and etoricoxib (10 mg/kg) daily for 21 days. On days 0, 3, 7, 14 and 21, pain was measured and histopathology of right knee joint was done on day 21. SMT produced analgesia in a dose-dependent manner as shown by mechanical, heat hyperalgesia, knee vocalization, knee squeeze test, and spontaneous motor activity test. SMT reduced NO production in synovial fluid. Histopathological findings indicated that SMT reduced disease progression as evident from complete cartilage formation in rats treated with SMT at 30 mg/kg. In conclusion, the results indicate that SMT attenuates the MIA-induced pain and histopathological changes in the knee joint. The antinociceptive and antiarthritic effects of SMT were mediated by inhibiting cartilage damage and suppression of NO in synovial fluid. It is suggested that SMT has potential as a therapeutic modality in the treatment of osteoarthritis.

Original languageEnglish (US)
Pages (from-to)764-772
Number of pages9
JournalPharmacology Biochemistry and Behavior
Volume103
Issue number4
DOIs
StatePublished - Feb 2013
Externally publishedYes

Fingerprint

Iodoacetates
Osteoarthritis
Pain
Knee Joint
Rats
Nitric Oxide
etoricoxib
Therapeutics
Synovial Fluid
Cartilage
Disease Progression
Knee
S-methylisothiopseudouronium
Intra-Articular Injections
Fluids
Hyperalgesia
Analgesia
Motor Activity
Hot Temperature

Keywords

  • iNOS
  • Monosodium iodoacetate
  • Osteoarthritis
  • Pain
  • S-methylisothiourea

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Pharmacology
  • Toxicology
  • Behavioral Neuroscience
  • Biological Psychiatry

Cite this

Effect of iNOS inhibitor S-methylisothiourea in monosodium iodoacetate-induced osteoathritic pain : Implication for osteoarthritis therapy. / More, Amar S.; Kumari, Rashmi R.; Gupta, Gaurav; Lingaraju, Madhu C.; Balaganur, Venkanna; Pathak, Nitya N.; Kumar, Dhirendra; Kumar, Dinesh; Sharma, Anil K.; Tandan, Surendra K.

In: Pharmacology Biochemistry and Behavior, Vol. 103, No. 4, 02.2013, p. 764-772.

Research output: Contribution to journalArticle

More, AS, Kumari, RR, Gupta, G, Lingaraju, MC, Balaganur, V, Pathak, NN, Kumar, D, Kumar, D, Sharma, AK & Tandan, SK 2013, 'Effect of iNOS inhibitor S-methylisothiourea in monosodium iodoacetate-induced osteoathritic pain: Implication for osteoarthritis therapy', Pharmacology Biochemistry and Behavior, vol. 103, no. 4, pp. 764-772. https://doi.org/10.1016/j.pbb.2012.12.013
More, Amar S. ; Kumari, Rashmi R. ; Gupta, Gaurav ; Lingaraju, Madhu C. ; Balaganur, Venkanna ; Pathak, Nitya N. ; Kumar, Dhirendra ; Kumar, Dinesh ; Sharma, Anil K. ; Tandan, Surendra K. / Effect of iNOS inhibitor S-methylisothiourea in monosodium iodoacetate-induced osteoathritic pain : Implication for osteoarthritis therapy. In: Pharmacology Biochemistry and Behavior. 2013 ; Vol. 103, No. 4. pp. 764-772.
@article{7d4379a5f5444e8a83548b103f6b5c71,
title = "Effect of iNOS inhibitor S-methylisothiourea in monosodium iodoacetate-induced osteoathritic pain: Implication for osteoarthritis therapy",
abstract = "Much information is available on the role of nitric oxide (NO) in osteoarthritis (OA). However, its role has not been studied in the monosodium iodoacetate (MIA)-induced model of osteoarthritic pain. The present study was undertaken in rats to investigate the effect of iNOS inhibitor S-methylisothiourea (SMT) in MIA-induced osteoathritic pain and disease progression in rats. Osteoarthritis was produced by single intra-articular injection of the MIA in the right knee joint on day 0. Treatment groups were orally gavazed with different doses of SMT (10, 30 and 100 mg/kg) and etoricoxib (10 mg/kg) daily for 21 days. On days 0, 3, 7, 14 and 21, pain was measured and histopathology of right knee joint was done on day 21. SMT produced analgesia in a dose-dependent manner as shown by mechanical, heat hyperalgesia, knee vocalization, knee squeeze test, and spontaneous motor activity test. SMT reduced NO production in synovial fluid. Histopathological findings indicated that SMT reduced disease progression as evident from complete cartilage formation in rats treated with SMT at 30 mg/kg. In conclusion, the results indicate that SMT attenuates the MIA-induced pain and histopathological changes in the knee joint. The antinociceptive and antiarthritic effects of SMT were mediated by inhibiting cartilage damage and suppression of NO in synovial fluid. It is suggested that SMT has potential as a therapeutic modality in the treatment of osteoarthritis.",
keywords = "iNOS, Monosodium iodoacetate, Osteoarthritis, Pain, S-methylisothiourea",
author = "More, {Amar S.} and Kumari, {Rashmi R.} and Gaurav Gupta and Lingaraju, {Madhu C.} and Venkanna Balaganur and Pathak, {Nitya N.} and Dhirendra Kumar and Dinesh Kumar and Sharma, {Anil K.} and Tandan, {Surendra K.}",
year = "2013",
month = "2",
doi = "10.1016/j.pbb.2012.12.013",
language = "English (US)",
volume = "103",
pages = "764--772",
journal = "Pharmacology Biochemistry and Behavior",
issn = "0091-3057",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Effect of iNOS inhibitor S-methylisothiourea in monosodium iodoacetate-induced osteoathritic pain

T2 - Implication for osteoarthritis therapy

AU - More, Amar S.

AU - Kumari, Rashmi R.

AU - Gupta, Gaurav

AU - Lingaraju, Madhu C.

AU - Balaganur, Venkanna

AU - Pathak, Nitya N.

AU - Kumar, Dhirendra

AU - Kumar, Dinesh

AU - Sharma, Anil K.

AU - Tandan, Surendra K.

PY - 2013/2

Y1 - 2013/2

N2 - Much information is available on the role of nitric oxide (NO) in osteoarthritis (OA). However, its role has not been studied in the monosodium iodoacetate (MIA)-induced model of osteoarthritic pain. The present study was undertaken in rats to investigate the effect of iNOS inhibitor S-methylisothiourea (SMT) in MIA-induced osteoathritic pain and disease progression in rats. Osteoarthritis was produced by single intra-articular injection of the MIA in the right knee joint on day 0. Treatment groups were orally gavazed with different doses of SMT (10, 30 and 100 mg/kg) and etoricoxib (10 mg/kg) daily for 21 days. On days 0, 3, 7, 14 and 21, pain was measured and histopathology of right knee joint was done on day 21. SMT produced analgesia in a dose-dependent manner as shown by mechanical, heat hyperalgesia, knee vocalization, knee squeeze test, and spontaneous motor activity test. SMT reduced NO production in synovial fluid. Histopathological findings indicated that SMT reduced disease progression as evident from complete cartilage formation in rats treated with SMT at 30 mg/kg. In conclusion, the results indicate that SMT attenuates the MIA-induced pain and histopathological changes in the knee joint. The antinociceptive and antiarthritic effects of SMT were mediated by inhibiting cartilage damage and suppression of NO in synovial fluid. It is suggested that SMT has potential as a therapeutic modality in the treatment of osteoarthritis.

AB - Much information is available on the role of nitric oxide (NO) in osteoarthritis (OA). However, its role has not been studied in the monosodium iodoacetate (MIA)-induced model of osteoarthritic pain. The present study was undertaken in rats to investigate the effect of iNOS inhibitor S-methylisothiourea (SMT) in MIA-induced osteoathritic pain and disease progression in rats. Osteoarthritis was produced by single intra-articular injection of the MIA in the right knee joint on day 0. Treatment groups were orally gavazed with different doses of SMT (10, 30 and 100 mg/kg) and etoricoxib (10 mg/kg) daily for 21 days. On days 0, 3, 7, 14 and 21, pain was measured and histopathology of right knee joint was done on day 21. SMT produced analgesia in a dose-dependent manner as shown by mechanical, heat hyperalgesia, knee vocalization, knee squeeze test, and spontaneous motor activity test. SMT reduced NO production in synovial fluid. Histopathological findings indicated that SMT reduced disease progression as evident from complete cartilage formation in rats treated with SMT at 30 mg/kg. In conclusion, the results indicate that SMT attenuates the MIA-induced pain and histopathological changes in the knee joint. The antinociceptive and antiarthritic effects of SMT were mediated by inhibiting cartilage damage and suppression of NO in synovial fluid. It is suggested that SMT has potential as a therapeutic modality in the treatment of osteoarthritis.

KW - iNOS

KW - Monosodium iodoacetate

KW - Osteoarthritis

KW - Pain

KW - S-methylisothiourea

UR - http://www.scopus.com/inward/record.url?scp=84873339951&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873339951&partnerID=8YFLogxK

U2 - 10.1016/j.pbb.2012.12.013

DO - 10.1016/j.pbb.2012.12.013

M3 - Article

C2 - 23287799

AN - SCOPUS:84873339951

VL - 103

SP - 764

EP - 772

JO - Pharmacology Biochemistry and Behavior

JF - Pharmacology Biochemistry and Behavior

SN - 0091-3057

IS - 4

ER -